Intervention 1: L-carnitine 750 mg per day (3 tablets) oral, manufactored by Pars Minoo (Tehran-Iran). Intervention 2: Placebo 750 mg/day (3 tablets) oral, manufactored by Pars Minoo(Tehran-Iran).
Sponsors
Isfahan university of medical sciences, Isfahan University of medical Sciences
Conditions
haemodialysis patients.
End-stage renal diseaseperitoneal dialysis patients.
End-stage renal disease
Phase 3
The effect of Carnitine on plasma Albomin level in haemodialysis patient
Active, not recruitingIRCT138804092106N1
Start: 2008-10-22Target: 22Updated: 2018-02-22
The effect of L-Carnitine on plasma Albomin level in peritoneal dialysis patients
Active, not recruitingIRCT138806022370N1
Start: 2008-08-22Target: 25Updated: 2018-02-22